IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+23.86%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$179M
AUM Growth
+$179M
(+15%)
Cap. Flow
-$570K
Cap. Flow
% of AUM
-0.32%
Top 10 Holdings %
Top 10 Hldgs %
44.86%
Holding
79
New
19
Increased
16
Reduced
19
Closed
13
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$10.7M |
| 2 |
AET
Aetna Inc
AET
|
$6.38M |
| 3 |
Karyopharm Therapeutics
KPTI
|
$3.53M |
| 4 |
Esperion Therapeutics
ESPR
|
$2.65M |
| 5 |
Cardinal Health
CAH
|
$2.45M |
Top Sells
| 1 |
Biogen
BIIB
|
$6.84M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$5.76M |
| 3 |
Zimmer Biomet
ZBH
|
$4.27M |
| 4 |
MZOR
Mazor Robotics Ltd.
MZOR
|
$3.48M |
| 5 |
Elevance Health
ELV
|
$2.88M |
Sector Composition
| 1 | Healthcare | 74.89% |
| 2 | Financials | 3.56% |
| 3 | Energy | 1.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
26
DELISTED
Immunomedics Inc
IMMU
| $2.27M | 1.12% |
350,000
+50,000
| +17% | +$324K |
|
27
Aclaris Therapeutics
ACRS
$223M
| $2.24M | 1.11% |
75,000
+25,000
| +50% | +$746K |
|
|
JUNO
28
DELISTED
Juno Therapeutics, Inc.
JUNO
| $2.22M | 1.1% |
+100,000
| New | +$2.22M |
|
|
SPNC
29
DELISTED
Spectranetics Corp
SPNC
| $2.18M | 1.08% |
75,000
-35,000
| -32% | -$1.02M |
|
|
TVTY
30
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $2.18M | 1.08% |
75,000
-25,000
| -25% | -$728K |
|
|
MDRX
31
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.9M | 0.94% |
150,000
+90,000
| +150% | +$1.14M |
|
|
LHCG
32
DELISTED
LHC Group LLC
LHCG
| $1.89M | 0.93% |
35,000
+5,000
| +17% | +$270K |
|
|
33
Zimmer Biomet
ZBH
$20.8B
| $1.83M | 0.91% |
15,000
-35,000
| -70% | -$4.27M |
|
34
Pacira BioSciences
PCRX
$1.22B
| $1.82M | 0.9% |
+40,000
| New | +$1.82M |
|
|
CCXI
35
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.82M | 0.9% |
250,000
-20,000
| -7% | -$146K |
|
|
MZOR
36
DELISTED
Mazor Robotics Ltd.
MZOR
| $1.73M | 0.85% |
58,000
-117,000
| -67% | -$3.48M |
|
|
XENT
37
DELISTED
Intersect ENT, Inc
XENT
| $1.72M | 0.85% |
100,000
+25,000
| +33% | +$429K |
|
38
Gilead Sciences
GILD
$140B
| $1.7M | 0.84% |
25,000
| – | – |
|
|
ALDR
39
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $1.56M | 0.77% |
75,000
-65,000
| -46% | -$1.35M |
|
40
AstraZeneca
AZN
$255B
| $1.56M | 0.77% |
50,000
| – | – |
|
|
AKAO
41
DELISTED
Achaogen, Inc.
AKAO
| $1.51M | 0.75% |
60,000
+10,000
| +20% | +$252K |
|
42
AnaptysBio
ANAB
$630M
| $1.39M | 0.69% |
+50,000
| New | +$1.39M |
|
43
CytomX Therapeutics
CTMX
$350M
| $1.3M | 0.64% |
+75,000
| New | +$1.3M |
|
|
EPZM
44
DELISTED
Epizyme, Inc
EPZM
| $1.29M | 0.64% |
+75,000
| New | +$1.29M |
|
|
IPXL
45
DELISTED
Impax Laboratories, Inc.
IPXL
| $1.27M | 0.63% |
+100,000
| New | +$1.27M |
|
|
DPLO
46
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1.2M | 0.59% |
75,000
+25,000
| +50% | +$399K |
|
47
Pacific Biosciences
PACB
$378M
| $1.11M | 0.55% |
215,000
+65,000
| +43% | +$336K |
|
|
ELGX
48
DELISTED
Endologix Inc
ELGX
| $1.09M | 0.54% |
+150,000
| New | +$1.09M |
|
|
RARX
49
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $1.07M | 0.53% |
50,000
| – | – |
|
|
ZYNE
50
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $1.01M | 0.5% |
+50,000
| New | +$1.01M |
|